ask our doctors

Lymphoma Lymphoblastic

Get the facts on Lymphoma Lymphoblastic treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Lymphoma Lymphoblastic prevention, screening, research, statistics and other Lymphoma Lymphoblastic related topics. We answer all your qestions about Lymphoma Lymphoblastic.

Question: What is the prognosis for lymphoblastic lymphoma???? What would the prognosis be for a 16yr old male with stage 3 lymphoblastic lymphoma???

Answer: Staging and grading Staging The stage of non-Hodgkin lymphoma describes how many groups of lymph nodes are affected, where they are in the body, and whether other organs, such as the bone marrow or liver, are affected. Stage 1 The lymphoma is only in one group of lymph nodes, in one particular area of the body.Stage 2 More than one group of lymph nodes is involved, but all the involved nodes are contained within either the upper half or the lower half of the body. The upper half of the body is above the sheet of muscle underneath the lungs (the diaphragm), and the lower half is below the diaphragm.Stage 3 Lymphoma is present in lymph nodes in both the upper and lower parts of the body (ie in lymph nodes both above and below the diaphragm). The spleen is considered as a lymph node in this staging system.Stage 4 The lymphoma has spread beyond lymph nodes to other lymphatic organs – for example, to sites such as the bone marrow, liver or lungs.


Lymphoma Lymphoblastic News

The Express Times - LehighValleyLive.com

Former Freedom swimmer Rob DelFranco diagnosed with Acute Lymphoblastic Lymphoma
The Express Times - LehighValleyLive.com
 

Another Year, Another High...

NASDAQ
A number of phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. Last December, the company presented interim ...
 

Bio-Path Holdings Successfully Completes Second Cohort in Phase I Clinical ...

EON: Enhanced Online News (press release)
... product candidate, BP-100-1.01 (Liposomal Grb-2), which is a systemic treatment for blood cancers including acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), acute lymphoblastic leukemia (ALL) and myelodysplastic syndrome (MDS).
 

Kansas City Star

2 Biotech Firms Bolster Their Drug Pipelines Through Deals
New York Times
 

Talon Therapeutics' Product Candidate Marqibo(R) to be Assessed by Oncologic ...

MarketWatch (press release)
Vincristine, a microtubule inhibitor, is FDA-approved for ALL and is widely used as a single agent and in combination regimens for treatment for hematologic malignancies such as lymphomas and leukemias. Talon's encapsulation formulation is designed to ...
 

Bloomberg

Amgen Agrees to Purchase Micromet for $1.16 Billion to Gain Leukemia Drug
Bloomberg
 

Access to new class of drugs in cancer care provides relief to both patients ...

pharmabiz.com
Three blood cancers: leukaemia, lymphoma and myeloma which are on the rise globally and in India with a specific T-Lineage sub-type prevalence of Acute Lymphoblastic Leukaemia (ALL), new drugs from pharma companies, treatment protocols extended by ...
 

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2012 Financial Results and ...

MarketWatch (press release)
Phase II trials are now in process that evaluate SAR3419: (1) as a single agent for diffuse large B-cell lymphoma (DLBCL); (2) in combination with Rituxan(R) (rituximab) for DLBCL; and (3) as a single agent for B-cell acute lymphoblastic leukemia ...
 

Equities.com

Healthcare Starts 2012 With a Flurry of Acquisitions
Equities.com
 

Did You Buy These Stocks?

NASDAQ
A number of Phase 1 and 2 studies with PCI-32765 are ongoing across a panel of B-cell malignancy disorders, including chronic lymphocytic leukemia, mantle cell lymphoma, and diffuse large B-cell lymphoma. In December of 2011, Pharmacyclics inked a deal ...